» Articles » PMID: 39843947

Profile and Resistance Levels of 136 Integron Resistance Genes

Overview
Publisher Nature Portfolio
Date 2025 Jan 22
PMID 39843947
Authors
Affiliations
Soon will be listed here.
Abstract

Integrons have played a major role in the rise and spread of multidrug resistance in Gram-negative pathogens and are nowadays commonplace among clinical isolates. These platforms capture, stockpile, and modulate the expression of more than 170 antimicrobial resistance cassettes (ARCs) against most clinically-relevant antibiotics. Despite their importance, our knowledge on their profile and resistance levels is patchy, because data is scattered in the literature, often reported in different genetic backgrounds and sometimes extrapolated from sequence similarity alone. Here we have generated a collection of 136 ARCs against 8 antibiotic families and disinfectants. Cassettes are cloned in a vector designed to mimic the genetic environment of a class 1 integron, and transformed in Escherichia coli. We have measured the minimal inhibitory concentration (MIC) to the most relevant molecules from each antibiotic family. With more than 500 MIC values, we provide an exhaustive and comparable quantitation of resistance conferred by ARCs. Our data confirm known resistance trends and profiles while revealing important differences among closely related genes. We have also detected genes that do not confer the expected resistance, to the point of challenging the role of the whole family of qac genes in resistance against disinfectants. Our work provides a detailed characterization of integron resistance genes at-a-glance.

Citing Articles

Integrons are anti-phage defence libraries in Vibrio parahaemolyticus.

Getz L, Fairburn S, Vivian Liu Y, Qian A, Maxwell K Nat Microbiol. 2025; 10(3):724-733.

PMID: 39870871 DOI: 10.1038/s41564-025-01927-7.


Chromosomal integrons are genetically and functionally isolated units of genomes.

Blanco P, Trigo da Roza F, Toribio-Celestino L, Garcia-Pastor L, Caselli N, Moron A Nucleic Acids Res. 2024; 52(20):12565-12581.

PMID: 39385642 PMC: 11551772. DOI: 10.1093/nar/gkae866.

References
1.
. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325):629-655. PMC: 8841637. DOI: 10.1016/S0140-6736(21)02724-0. View

2.
Kotra L, Haddad J, Mobashery S . Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob Agents Chemother. 2000; 44(12):3249-56. PMC: 90188. DOI: 10.1128/AAC.44.12.3249-3256.2000. View

3.
Poirel L, Le Thomas I, Naas T, Karim A, Nordmann P . Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother. 2000; 44(3):622-32. PMC: 89737. DOI: 10.1128/AAC.44.3.622-632.2000. View

4.
Escudero J, Loot C, Nivina A, Mazel D . The Integron: Adaptation On Demand. Microbiol Spectr. 2015; 3(2):MDNA3-0019-2014. DOI: 10.1128/microbiolspec.MDNA3-0019-2014. View

5.
Ramirez M, Tolmasky M . Aminoglycoside modifying enzymes. Drug Resist Updat. 2010; 13(6):151-71. PMC: 2992599. DOI: 10.1016/j.drup.2010.08.003. View